世界の皮膚がんの診断と治療市場：市場規模・現状・予測

• 英文タイトル：Global Skin Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N8050
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、104ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、皮膚がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（日光角化症（AK）、ベース細胞がん（BCC）、扁平上皮がん（SCC）、メラノーマ）、用途別（病院、がん研究センター、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・皮膚がんの診断と治療の世界市場規模
・主要企業別市場シェア
・皮膚がんの診断と治療の世界市場規模：種類別（日光角化症（AK）、ベース細胞がん（BCC）、扁平上皮がん（SCC）、メラノーマ）
・皮膚がんの診断と治療の世界市場規模：用途別（病院、がん研究センター、診療所）
・皮膚がんの診断と治療のアメリカ市場規模（種類別、用途別）
・皮膚がんの診断と治療のヨーロッパ市場規模（種類別、用途別）
・皮膚がんの診断と治療の中国市場規模（種類別、用途別）
・皮膚がんの診断と治療の日本市場規模（種類別、用途別）
・皮膚がんの診断と治療の東南アジア市場規模（種類別、用途別）
・皮膚がんの診断と治療のインド市場規模（種類別、用途別）
・皮膚がんの診断と治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・皮膚がんの診断と治療の世界市場予測（2019年-2025年）
・皮膚がんの診断と治療の地域別市場予測（2019年-2025年）
...

Skin cancer is the uncontrolled development of anomalous skin cells.The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer.
In 2018, the global Skin Cancer Diagnosis and Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Skin Cancer Diagnosis and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Skin Cancer Diagnosis and Therapeutics development in United States, Europe and China.

The key players covered in this study
Agilent
Amgen
Aqua Pharmaceuticals
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
Elekta
Eli Lilly
Roche
GSK
iCAD
Bausch Health
Merck
Novartis
Pfizer
QIAGEN
Sanofi
Teva Pharmaceutical
Varian Medical Systems

Market segment by Type, the product can be split into
Actinic Keratoses (AK)
Based cell carcinoma (BCC)
Squamous cell carcinoma (SCC)
Melanoma

Market segment by Application, split into
Hospitals
Cancer research centers
Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Skin Cancer Diagnosis and Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Skin Cancer Diagnosis and Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Skin Cancer Diagnosis and Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Actinic Keratoses (AK)
1.4.3 Based cell carcinoma (BCC)
1.4.4 Squamous cell carcinoma (SCC)
1.4.5 Melanoma
1.5 Market by Application
1.5.1 Global Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Cancer research centers
1.5.4 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Skin Cancer Diagnosis and Therapeutics Market Size
2.2 Skin Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Skin Cancer Diagnosis and Therapeutics Market Size by Regions (2014-2025)
2.2.2 Skin Cancer Diagnosis and Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Skin Cancer Diagnosis and Therapeutics Market Size by Manufacturers
3.1.1 Global Skin Cancer Diagnosis and Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Skin Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Skin Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.3 Key Players Skin Cancer Diagnosis and Therapeutics Product/Solution/Service
3.4 Date of Enter into Skin Cancer Diagnosis and Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019)
4.2 Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019)
5.2 Skin Cancer Diagnosis and Therapeutics Key Players in United States
5.3 United States Skin Cancer Diagnosis and Therapeutics Market Size by Type
5.4 United States Skin Cancer Diagnosis and Therapeutics Market Size by Application

6 Europe
6.1 Europe Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019)
6.2 Skin Cancer Diagnosis and Therapeutics Key Players in Europe
6.3 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type
6.4 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application

7 China
7.1 China Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019)
7.2 Skin Cancer Diagnosis and Therapeutics Key Players in China
7.3 China Skin Cancer Diagnosis and Therapeutics Market Size by Type
7.4 China Skin Cancer Diagnosis and Therapeutics Market Size by Application

8 Japan
8.1 Japan Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019)
8.2 Skin Cancer Diagnosis and Therapeutics Key Players in Japan
8.3 Japan Skin Cancer Diagnosis and Therapeutics Market Size by Type
8.4 Japan Skin Cancer Diagnosis and Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019)
9.2 Skin Cancer Diagnosis and Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Type
9.4 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Application

10 India
10.1 India Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019)
10.2 Skin Cancer Diagnosis and Therapeutics Key Players in India
10.3 India Skin Cancer Diagnosis and Therapeutics Market Size by Type
10.4 India Skin Cancer Diagnosis and Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Skin Cancer Diagnosis and Therapeutics Market Size (2014-2019)
11.2 Skin Cancer Diagnosis and Therapeutics Key Players in Central & South America
11.3 Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Type
11.4 Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Application

12 International Players Profiles
12.1 Agilent
12.1.1 Agilent Company Details
12.1.2 Company Description and Business Overview
12.1.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.1.4 Agilent Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.1.5 Agilent Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.2.4 Amgen Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Aqua Pharmaceuticals
12.3.1 Aqua Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.3.4 Aqua Pharmaceuticals Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.3.5 Aqua Pharmaceuticals Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.4.4 AstraZeneca Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.4.5 AstraZeneca Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.5.4 Bristol-Myers Squibb Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Daiichi Sankyo
12.6.1 Daiichi Sankyo Company Details
12.6.2 Company Description and Business Overview
12.6.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.6.4 Daiichi Sankyo Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.6.5 Daiichi Sankyo Recent Development
12.7 Elekta
12.7.1 Elekta Company Details
12.7.2 Company Description and Business Overview
12.7.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.7.4 Elekta Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.7.5 Elekta Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Company Details
12.8.2 Company Description and Business Overview
12.8.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.8.4 Eli Lilly Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.8.5 Eli Lilly Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.9.4 Roche Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.9.5 Roche Recent Development
12.10 GSK
12.10.1 GSK Company Details
12.10.2 Company Description and Business Overview
12.10.3 Skin Cancer Diagnosis and Therapeutics Introduction
12.10.4 GSK Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
12.10.5 GSK Recent Development
12.11 iCAD
12.12 Bausch Health
12.13 Merck
12.14 Novartis
12.15 Pfizer
12.16 QIAGEN
12.17 Sanofi
12.18 Teva Pharmaceutical
12.19 Varian Medical Systems

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Skin Cancer Diagnosis and Therapeutics Key Market Segments
Table Key Players Skin Cancer Diagnosis and Therapeutics Covered
Table Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Market Share by Type 2014-2025
Figure Actinic Keratoses (AK) Figures
Table Key Players of Actinic Keratoses (AK)
Figure Based cell carcinoma (BCC) Figures
Table Key Players of Based cell carcinoma (BCC)
Figure Squamous cell carcinoma (SCC) Figures
Table Key Players of Squamous cell carcinoma (SCC)
Figure Melanoma Figures
Table Key Players of Melanoma
Table Global Skin Cancer Diagnosis and Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Cancer research centers Case Studies
Figure Clinics Case Studies
Figure Skin Cancer Diagnosis and Therapeutics Report Years Considered
Table Global Skin Cancer Diagnosis and Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions 2014-2019
Figure Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions 2014-2019
Figure Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Skin Cancer Diagnosis and Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Skin Cancer Diagnosis and Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Share by Manufacturers in 2018
Table Global Skin Cancer Diagnosis and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Skin Cancer Diagnosis and Therapeutics Product/Solution/Service
Table Date of Enter into Skin Cancer Diagnosis and Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Type (2014-2019)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Application (2014-2019)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Application in 2018
Figure United States Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table United States Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table United States Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure Europe Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure China Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table China Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table China Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure Japan Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table Japan Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table Japan Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure India Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table India Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table India Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Skin Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Skin Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Skin Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Table Agilent Company Details
Table Agilent Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019) (Million US$)
Figure Agilent Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Agilent Recent Development
Table Amgen Company Details
Table Amgen Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table Aqua Pharmaceuticals Company Details
Table Aqua Pharmaceuticals Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Aqua Pharmaceuticals Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Aqua Pharmaceuticals Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Elekta Company Details
Table Elekta Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Elekta Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Elekta Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Roche Company Details
Table Roche Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Roche Recent Development
Table GSK Company Details
Table GSK Revenue in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2014-2019)
Table GSK Recent Development
Table iCAD Company Details
Table Bausch Health Company Details
Table Merck Company Details
Table Novartis Company Details
Table Pfizer Company Details
Table QIAGEN Company Details
Table Sanofi Company Details
Table Teva Pharmaceutical Company Details
Table Varian Medical Systems Company Details
Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Regions in 2025
Figure United States Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Skin Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size by Product (2019-2025)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size by Product in 2025
Table Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2025)
Figure Global Skin Cancer Diagnosis and Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の肺がんの診断と治療市場：市場規模・現状・予測

Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7483 2019年6月14日 103Pages
当資料は、肺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（非小細胞肺がん、小細胞肺がん）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の中咽頭がんの診断と治療法市場：市場規模・現状・予測

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7722 2019年6月14日 99Pages
当資料は、中咽頭がんの診断と治療法のグローバル市場について調査・分析したレポートで、種類別（内視鏡検査、生検、イメージング）、用途別（病院、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の非侵襲がん診断市場：市場規模・現状・予測

Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2019-2025
QYR9N7685 2019年6月14日 91Pages
当資料は、非侵襲がん診断のグローバル市場について調査・分析したレポートで、種類別（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別（血液がん、固形腫瘍、乳がん、肺癌、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界の前立腺がんの診断と治療市場：市場規模・現状・予測

Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2019-2025
QYR9N7892 2019年6月14日 105Pages
当資料は、前立腺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（前立腺特異抗原検査（PSA）、直腸デジタル検査（DRE））、用途別（病院、診療所、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...

世界の非黒色腫皮膚がんの治療市場：市場規模・現状・予測

Global Non-Melanoma Skin Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7688 2019年6月14日 101Pages
当資料は、非黒色腫皮膚がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、光線力学療法）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...

世界の皮膚ガン市場：市場規模・現状・予測

Global Skin Cancer Market Size, Status and Forecast 2019-2025
QYR9N8049 2019年6月14日 103Pages
当資料は、皮膚ガンのグローバル市場について調査・分析したレポートで、種類別（基底細胞がん、扁平上皮がん）、用途別（病院、診療所、診断センター、がん研究所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の膵がん治療市場：市場規模・現状・予測

Global Pancreatic Cancer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7757 2019年6月14日 99Pages
当資料は、膵がん治療のグローバル市場について調査・分析したレポートで、種類別（生物学、化学療法、ターゲット療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
<...

世界の移行上皮がん治療薬市場：市場規模・現状・予測

Global Transitional Cell Cancer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N8141 2019年6月14日 95Pages
当資料は、移行上皮がん治療薬のグローバル市場について調査・分析したレポートで、種類別（膀胱腫瘍の経尿道的切除、膀胱切除術、尿路変更）、用途別（病院、がん研究所、多専門クリニック、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企...

世界のペプチドベースのがん治療薬市場：市場規模・現状・予測

Global Peptide Based Cancer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7786 2019年6月14日 93Pages
当資料は、ペプチドベースのがん治療薬のグローバル市場について調査・分析したレポートで、種類別（ゴセレリン、ボルテゾミブ、ロイプロレリン、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報...

世界の肌の交換市場：市場規模・現状・予測

Global Skin Replacement Market Size, Status and Forecast 2019-2025
QYR9N8053 2019年6月14日 97Pages
当資料は、肌の交換のグローバル市場について調査・分析したレポートで、種類別（エピセル、インテグラ）、用途別（化学薬品、化粧品、製薬）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・肌の交...

世界の肺がんの診断と治療市場：市場規模・現状・予測 Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the g…
世界の中咽頭がんの診断と治療法市場：市場規模・現状・予測 Oropharyngeal cancer is a malignant tumour that starts in the cells of the oropharynx. Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. Additionally, increasing geriatric population and rising oropharyngeal cancer associated with them is another factor d…
世界の移行上皮がん治療薬市場：市場規模・現状・予測 Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra.Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. In 2…
世界の皮膚ガン市場：市場規模・現状・予測 Skin cancer is the most common type of cancer, which arise due to uncontrolled growth of abnormal skin cells. It occurs when skin cells are damaged by unrepaired DNA or genetic defects that lead the uncontrolled growth of cells in the skin.Asia Pacific is the fastest growing skin cancer market. Japa…
世界の非黒色腫皮膚がんの治療市場：市場規模・現状・予測 Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikel…